STOCK TITAN

[Form 4] UFP Technologies Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Daniel C. Croteau, a director of UFP Technologies, acquired 1,318 shares of common stock on 08/07/2025 at a reported price of $22.36 per share, increasing his direct beneficial ownership to 3,728 shares. The transaction corresponds to the exercise of a stock option with a $22.36 exercise price originally exercisable on 12/16/2015 and expiring on 12/16/2025. The Form 4 was signed by an attorney-in-fact on 08/14/2025.

Daniel C. Croteau, amministratore di UFP Technologies, ha acquistato 1.318 azioni ordinarie il 07/08/2025 al prezzo segnalato di $22,36 per azione, portando la sua partecipazione diretta a 3.728 azioni. L'operazione deriva dall'esercizio di un'opzione con prezzo di esercizio di $22,36, originariamente esercitabile dal 16/12/2015 e in scadenza il 16/12/2025. Il Form 4 è stato firmato da un procuratore il 14/08/2025.

Daniel C. Croteau, director de UFP Technologies, adquirió 1.318 acciones ordinarias el 07/08/2025 a un precio informado de $22,36 por acción, elevando su propiedad directa a 3.728 acciones. La operación corresponde al ejercicio de una opción con precio de ejercicio de $22,36, inicialmente ejercitable el 16/12/2015 y con vencimiento el 16/12/2025. El Form 4 fue firmado por un apoderado el 14/08/2025.

Daniel C. Croteau, UFP Technologies의 이사는 2025-08-07에 보통주 1,318주를 주당 $22.36의 보고된 가격으로 취득하여 직접 보유 지분을 3,728주로 늘렸습니다. 이 거래는 행사가격 $22.36의 스톡옵션 행사를 통해 이루어졌으며, 해당 옵션은 원래 2015-12-16에 행사 가능하고 2025-12-16에 만료됩니다. Form 4는 2025-08-14에 대리인이 서명했습니다.

Daniel C. Croteau, administrateur de UFP Technologies, a acquis 1 318 actions ordinaires le 07/08/2025 au prix déclaré de 22,36 $ par action, portant sa détention directe à 3 728 actions. La transaction correspond à l'exercice d'une option d'achat au prix d'exercice de 22,36 $, initialement exerçable le 16/12/2015 et expirant le 16/12/2025. Le Form 4 a été signé par un mandataire le 14/08/2025.

Daniel C. Croteau, Direktor von UFP Technologies, erwarb am 07.08.2025 1.318 Stammaktien zu einem gemeldeten Preis von $22,36 je Aktie und erhöhte damit sein direktes wirtschaftliches Eigentum auf 3.728 Aktien. Die Transaktion entspricht der Ausübung einer Aktienoption mit einem Ausübungspreis von $22,36, die ursprünglich ab dem 16.12.2015 ausübbar war und am 16.12.2025 verfällt. Das Form 4 wurde am 14.08.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Director increased direct ownership by acquiring 1,318 shares, bringing total direct holdings to 3,728 shares.
  • Exercise used existing options with an exercise price equal to the reported transaction price ($22.36), indicating conversion of vested equity rather than an open-market purchase.
Negative
  • None.

Insights

TL;DR: Director exercised options to acquire 1,318 shares at $22.36, increasing direct holdings to 3,728 shares.

The filing documents a routine insider exercise of previously granted stock options: 1,318 options were exercised at the option exercise price of $22.36, producing 1,318 shares recorded as acquired on 08/07/2025 and raising the reporting person’s direct holdings to 3,728 shares. The option grant referenced was exercisable beginning 12/16/2015 and expires 12/16/2025. This is a non-cash-to-company change in ownership driven by the reporting person’s option exercise.

TL;DR: A director converted vested options into shares, a common alignment action between management and shareholders.

The Form 4 shows a director converting vested equity into common stock, a typical retention/alignment mechanism. The transaction was executed by an attorney-in-fact and properly reported. There are no disclosures in this filing of sales, transfers to related parties, or other arrangements; ownership after the transaction is documented as direct beneficial ownership of 3,728 shares.

Daniel C. Croteau, amministratore di UFP Technologies, ha acquistato 1.318 azioni ordinarie il 07/08/2025 al prezzo segnalato di $22,36 per azione, portando la sua partecipazione diretta a 3.728 azioni. L'operazione deriva dall'esercizio di un'opzione con prezzo di esercizio di $22,36, originariamente esercitabile dal 16/12/2015 e in scadenza il 16/12/2025. Il Form 4 è stato firmato da un procuratore il 14/08/2025.

Daniel C. Croteau, director de UFP Technologies, adquirió 1.318 acciones ordinarias el 07/08/2025 a un precio informado de $22,36 por acción, elevando su propiedad directa a 3.728 acciones. La operación corresponde al ejercicio de una opción con precio de ejercicio de $22,36, inicialmente ejercitable el 16/12/2015 y con vencimiento el 16/12/2025. El Form 4 fue firmado por un apoderado el 14/08/2025.

Daniel C. Croteau, UFP Technologies의 이사는 2025-08-07에 보통주 1,318주를 주당 $22.36의 보고된 가격으로 취득하여 직접 보유 지분을 3,728주로 늘렸습니다. 이 거래는 행사가격 $22.36의 스톡옵션 행사를 통해 이루어졌으며, 해당 옵션은 원래 2015-12-16에 행사 가능하고 2025-12-16에 만료됩니다. Form 4는 2025-08-14에 대리인이 서명했습니다.

Daniel C. Croteau, administrateur de UFP Technologies, a acquis 1 318 actions ordinaires le 07/08/2025 au prix déclaré de 22,36 $ par action, portant sa détention directe à 3 728 actions. La transaction correspond à l'exercice d'une option d'achat au prix d'exercice de 22,36 $, initialement exerçable le 16/12/2015 et expirant le 16/12/2025. Le Form 4 a été signé par un mandataire le 14/08/2025.

Daniel C. Croteau, Direktor von UFP Technologies, erwarb am 07.08.2025 1.318 Stammaktien zu einem gemeldeten Preis von $22,36 je Aktie und erhöhte damit sein direktes wirtschaftliches Eigentum auf 3.728 Aktien. Die Transaktion entspricht der Ausübung einer Aktienoption mit einem Ausübungspreis von $22,36, die ursprünglich ab dem 16.12.2015 ausübbar war und am 16.12.2025 verfällt. Das Form 4 wurde am 14.08.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CROTEAU DANIEL C

(Last) (First) (Middle)
C/O UFP TECHNOLOGIES, INC.
100 HALE STREET

(Street)
NEWBURYPORT MA 01950

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UFP TECHNOLOGIES INC [ UFPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 Par Value 08/07/2025 M 1,318 A $22.36 3,728 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $22.36 08/07/2025 M 1,318 12/16/2015 12/16/2025 Common Stock, $.01 Par Value 1,318 $0 0 D
Explanation of Responses:
Patrick J. Kinney, Jr. as attorney-in-fact for Daniel C. Croteau 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did UFPT director Daniel C. Croteau report on Form 4?

The Form 4 reports that Daniel C. Croteau acquired 1,318 shares on 08/07/2025, recorded at a price of $22.36 per share.

How many shares does Daniel C. Croteau own after the reported transaction (UFPT)?

Following the reported transaction, Croteau beneficially owns 3,728 shares directly.

Was the acquisition of UFPT shares the result of an option exercise?

Yes. The filing references a stock option with an exercise price of $22.36, exercisable from 12/16/2015 and expiring 12/16/2025, and shows 1,318 options converted into 1,318 shares.

When was the Form 4 signed and who signed it?

The Form 4 was signed on 08/14/2025 by Patrick J. Kinney, Jr. acting as attorney-in-fact for Daniel C. Croteau.

Did the filing indicate any sales or dispositions of UFPT shares by the reporting person?

No. The filing reports an acquisition of shares; there are no dispositions or sales recorded in this Form 4.
Ufp Technologies

NASDAQ:UFPT

UFPT Rankings

UFPT Latest News

UFPT Latest SEC Filings

UFPT Stock Data

1.69B
7.42M
3.72%
115.63%
18.34%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEWBURYPORT